Moderna Settles COVID Vax Patent Case In Europe
Moderna has settled a patent infringement claim in Europe targeting its COVID-19 vaccine after agreeing to pay at least $950 million to a U.S. drugmaker and its licensee, the Unified Patent...To view the full article, register now.
Already a subscriber? Click here to view full article